Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zoetis Inc.ZTS · Entity 679 | Executive Vice President | May 03, 2021 | May 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zoetis Inc.
Report date May 03, 2021 · Filed May 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,300 |
Ending reported balance
After 2021-05-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-05-03 · Exercise / conversion · Acquired 820 · Balance 9,625 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Row 2 · 2021-05-03 · Exercise / conversion · Acquired 728 · Balance 10,353 Row 3 · 2021-05-03 · Sale · Disposed 2,053 · Balance 8,300 F2: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. |
| Stock OptionSEC Table II · derivative / convertible security | Direct | 46,864 |
Reported balance
After 2021-05-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-05-03 · Exercise / conversion · Disposed 820 · Balance 46,864 F3: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4: 820 options granted January 31, 2013 at an exercise price of $26.00 per option. F5: Each option vests on the third anniversary of the date of grant. F6: Each option expires on the tenth anniversary of the date of grant. F7: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. |
| Stock OptionSEC Table II · derivative / convertible security | Direct | 46,136 |
Reported balance
After 2021-05-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-05-03 · Exercise / conversion · Disposed 728 · Balance 46,136 F3: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8: 728 options granted March 4, 2014 at an exercise price of $30.89 per option. F5: Each option vests on the third anniversary of the date of grant. F6: Each option expires on the tenth anniversary of the date of grant. F9: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 5,824 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
F2: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F4: 820 options granted January 31, 2013 at an exercise price of $26.00 per option.
F5: Each option vests on the third anniversary of the date of grant.
F6: Each option expires on the tenth anniversary of the date of grant.
F7: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.
F8: 728 options granted March 4, 2014 at an exercise price of $30.89 per option.
F9: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 5,824 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 4, 2021 20:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,136 Underlying: Common Stock · 728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 728 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 5,824 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,864 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 820 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,053 | $174.70 | $358,659.10 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,300 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 728 | $30.89 | $22,487.92 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 820 | $26.00 | $21,320.00 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 21:10 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 304.7988 | $49.95 | $15,224.70 |
DisclosureSEC source: 0001555280-21-000191 · wf-form4_161834820662219.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,103.8872 Underlying: Common Stock · 95.2437 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 20:33 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000187 · wf-form4_161730914388361.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,684 Underlying: Common Stock · 729 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 729 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 7,380 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 20:33 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000187 · wf-form4_161730914388361.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,413 Underlying: Common Stock · 821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 821 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,380 options granted January 31, 2013 at an exercise price of $26.00 per option; 7,281 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 20:33 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,055 | $158.05 | $324,792.75 |
DisclosureSEC source: 0001555280-21-000187 · wf-form4_161730914388361.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,805 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 20:33 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 729 | $30.89 | $22,518.81 |
DisclosureSEC source: 0001555280-21-000187 · wf-form4_161730914388361.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 20:33 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 821 | $26.00 | $21,346.00 |
DisclosureSEC source: 0001555280-21-000187 · wf-form4_161730914388361.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:13 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 427.266 | $49.51 | $21,153.94 |
DisclosureSEC source: 0001555280-21-000170 · wf-form4_161722517387924.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,799.0884 Underlying: Common Stock · 133.556 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:25 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000154 · wf-form4_161480668456881.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,234 Underlying: Common Stock · 729 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 729 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 8,201 options granted January 31, 2013 at an exercise price of $26.00 per option; 7,281 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:25 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000154 · wf-form4_161480668456881.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,963 Underlying: Common Stock · 821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 821 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 8,201 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:25 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,055 | $156.11 | $320,806.05 |
DisclosureSEC source: 0001555280-21-000154 · wf-form4_161480668456881.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,310 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:25 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 729 | $30.89 | $22,518.81 |
DisclosureSEC source: 0001555280-21-000154 · wf-form4_161480668456881.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:25 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 821 | $26.00 | $21,346.00 |
DisclosureSEC source: 0001555280-21-000154 · wf-form4_161480668456881.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 1,351.9068 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · derivative · entry 6 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,351.9068 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 926.3818 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,993.8364 Underlying: Common Stock · 926.3818 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 926.3818 RSUs vested on February 13, 2021; 866.9394 RSUs will vest on February 12, 2022; 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 926.3818 RSUs vested on February 13, 2021; 866.9394 RSUs will vest on February 12, 2022; 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 926.3818 RSUs vested on February 13, 2021; 866.9394 RSUs will vest on February 12, 2022; 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 692 | $166.71 | $115,363.32 |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · nonDerivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,815 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,351 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 474 | $166.71 | $79,020.54 |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,156 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:45 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000133 · wf-form4_161360186269566.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,784 Underlying: Common Stock · 729 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 729 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,513 Underlying: Common Stock · 821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 821 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,054 | $161.15 | $331,002.10 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,704 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 729 | $30.89 | $22,518.81 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 22:16 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 821 | $26.00 | $21,346.00 |
DisclosureSEC source: 0001555280-21-000100 · wf-form4_161351374187911.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:13 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 6,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000085 · wf-form4_161317156891689.xml · derivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,334 Underlying: Common Stock · 6,610 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:13 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000085 · wf-form4_161317156891689.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,920.2182 Underlying: Common Stock · 1,556 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 926.3818 RSUs will vest on February 13, 2021; 866.9394 RSUs will vest on February 12, 2022; 1,570.8970 RSUs will vest on February 11, 2023; and 1,556 RSUs will vest on February 10, 2024. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:03 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 1,351.9068 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000032 · wf-form4_161308460837183.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351.9068 Underlying: Common Stock · 1,351.9068 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 22:40 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 140.3364 | $50.36 | $7,067.34 |
DisclosureSEC source: 0001555280-21-000010 · wf-form4_161118241424842.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,371.8224 Underlying: Common Stock · 43.7444 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:21 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 117.7857 | $51.43 | $6,057.72 |
DisclosureSEC source: 0001555280-20-000295 · wf-form4_160262406913108.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,231.486 Underlying: Common Stock · 36.618 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:41 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 156.1153 | $45.27 | $7,067.34 |
DisclosureSEC source: 0001555280-20-000240 · wf-form4_159536405431970.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,113.7003 Underlying: Common Stock · 48.8548 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:12 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 160.5479 | $38.93 | $6,250.13 |
DisclosureSEC source: 0001555280-20-000184 · wf-form4_158715793941248.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,957.585 Underlying: Common Stock · 50.4816 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 23:14 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 798.6623 | $37.07 | $29,606.41 |
DisclosureSEC source: 0001555280-20-000161 · wf-form4_158586922800393.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797.0371 Underlying: Common Stock · 251.5627 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 1,736.6726 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · derivative · entry 6 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,736.6726 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 1,173.0694 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345.1646 Underlying: Common Stock · 1,173.0694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,173.0694 RSUs vested on February 14, 2020; 921.1352 RSUs will vest on February 13, 2021; 862.0294 RSUs will vest on February 12, 2022; and 1,562 RSUs will vest on February 11, 2023. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,173.0694 RSUs vested on February 14, 2020; 921.1352 RSUs will vest on February 13, 2021; 862.0294 RSUs will vest on February 12, 2022; and 1,562 RSUs will vest on February 11, 2023. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,173.0694 RSUs vested on February 14, 2020; 921.1352 RSUs will vest on February 13, 2021; 862.0294 RSUs will vest on February 12, 2022; and 1,562 RSUs will vest on February 11, 2023. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 595 | $144.17 | $85,781.15 |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · nonDerivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,208 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 402 | $144.17 | $57,956.34 |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · nonDerivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,067 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000113 · wf-form4_158214978554074.xml · nonDerivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:11 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 1,736.6726 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000082 · wf-form4_158163549331210.xml · derivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,736.6726 Underlying: Common Stock · 1,736.6726 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2017-2019 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:11 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 6,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000082 · wf-form4_158163549331210.xml · derivative · entry 2 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,724 Underlying: Common Stock · 6,633 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; and 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,843 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; and 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:11 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000082 · wf-form4_158163549331210.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518.234 Underlying: Common Stock · 1,562 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 1,173.0694 RSUs will vest on February 14, 2020; 921.1352 RSUs will vest on February 13, 2021; 862.0294 RSUs will vest on February 12, 2022; and 1,562 RSUs will vest on February 11, 2023. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:54 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 138.0232 | $42.28 | $5,835.62 |
DisclosureSEC source: 0001555280-20-000012 · wf-form4_157903883124524.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,998.3748 Underlying: Common Stock · 43.0451 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.